The life expectancy for adults diagnosed with anaplastic astrocytoma typically ranges from two to five years, according to Medscape. The disease's prognosis in individuals varies based upon age, efficacy of treatment and the disease's impact upon bodily functions.
Anaplastic astrocytoma is a malignant brain cancer, explains the National Organization for Rare Disorders. Astrocytomas arise from brain cells called astrocytes.
In adults, the disease usually develops between ages 30 and 50, states Medscape. More men than women develop the disease. The disease does not intrinsically behave differently among different races, though sociological and demographic factors may impact the distribution of morbidity and mortality among different racial or ethnic groups.